文献速递老年慢病共病管理老年综合评估

糖尿病而非糖尿病前期与社区老年人无残疾生存期丢失相关:ASPREE试验事后分析

Prediabetes, diabetes and loss of disability-free survival in a community-based older cohort: a post-hoc analysis of the ASPirin in Reducing Events in the Elderly trial.
PubMed 文献 · Age Ageing · 2023-01-01

该事后分析纳入ASPREE随机试验中18,816名≥70岁、无心血管事件、痴呆和躯体残疾的社区老年人,按基线血糖状态分为正常血糖、糖尿病前期和糖尿病,中位随访6.9年。与正常血糖相比,糖尿病与无残疾生存期丢失风险升高相关(加权HR 1.39,95%CI 1.21-1.60),而糖尿病前期未显示超额风险(HR 1.02,95%CI 0.93-1.12)。

要点

  • 糖尿病与无残疾生存期丢失风险升高相关(加权HR 1.39,95%CI 1.21-1.60)。
  • 糖尿病与持续性躯体残疾风险升高相关(加权HR 1.73,95%CI 1.35-2.22)。
  • 糖尿病前期未显示无残疾生存期丢失的超额风险(加权HR 1.02,95%CI 0.93-1.12)。

核心结论

  • 在社区老年人中,糖尿病与无残疾生存期丢失、认知障碍无痴呆和心血管结局风险升高相关,而糖尿病前期则没有。

研究设计与样本

  • ASPREE随机试验的事后分析,纳入19,114名≥70岁社区参与者,其中18,816名有足够信息确定基线糖尿病状态者纳入分析,中位随访6.9年。

主要发现

  • 与正常血糖相比,糖尿病组的无残疾生存期丢失风险更高(加权HR 1.39,95%CI 1.21-1.60)。
  • 与正常血糖相比,糖尿病组的全因死亡风险更高(加权HR 1.45,95%CI 1.23-1.72)。
  • 与正常血糖相比,糖尿病组的持续性躯体残疾风险更高(加权HR 1.73,95%CI 1.35-2.22)。
  • 与正常血糖相比,糖尿病组的认知障碍无痴呆风险更高(加权HR 1.22,95%CI 1.08-1.38),但痴呆风险无显著差异(加权HR 1.13,95%CI 0.87-1.47)。
  • 与正常血糖相比,糖尿病组的主要不良心血管事件风险更高(加权HR 1.30,95%CI 1.04-1.63),任何心血管事件风险也更高(加权HR 1.25,95%CI 1.02-1.54)。

关键数值与推荐

  • 正常血糖定义为空腹血糖<5.6 mmol/l(占64%),糖尿病前期定义为空腹血糖5.6至<7.0 mmol/l(占26%),糖尿病定义为自我报告或空腹血糖≥7.0 mmol/l或使用降糖药物(占11%)。
  • 糖尿病前期组无残疾生存期丢失风险与正常血糖组无显著差异(加权HR 1.02,95%CI 0.93-1.12),其他结局亦无超额风险。

临床怎么用

  • 原文指出,在这一年龄组中预防或治疗糖尿病的影响值得更密切关注。

局限性

  • 原文未述局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Evidence for the prognostic implications of hyperglycaemia in older adults is inconsistent. OBJECTIVE: To evaluate disability-free survival (DFS) in older individuals by glycaemic status. METHODS: This analysis used data from a randomised trial recruiting 19,114 community-based participants aged ≥70 years, who had no prior cardiovascular events, dementia and physical disability. Participants with sufficient information to ascertain their baseline diabetes status were categorised as having normoglycaemia (fasting plasma glucose [FPG] < 5.6 mmol/l, 64%), prediabetes (FPG 5.6 to <7.0 mmol/l, 26%) and diabetes (self-report or FPG ≥ 7.0 mmol/l or use of glucose-lowering agents, 11%). The primary outcome was loss of disability-free survival (DFS), a composite of all-cause mortality, persistent physical disability or dementia. Other outcomes included the three individual components of the DFS loss, as well as cognitive impairment-no dementia (CIND), major adverse cardiovascular events (MACE) and any cardiovascular event. Cox models were used for outcome analyses, with covariate adjustment using inverse-probability weighting. RESULTS: We included 18,816 participants (median follow-up: 6.9 years). Compared to normoglycaemia, participants with diabetes had greater risks of DFS loss (weighted HR: 1.39, 95% CI 1.21-1.60), all-cause mortality (1.45, 1.23-1.72), persistent physical disability (1.73, 1.35-2.22), CIND (1.22, 1.08-1.38), MACE (1.30, 1.04-1.63) and cardiovascular events (1.25, 1.02-1.54) but not dementia (1.13, 0.87-1.47). The prediabetes group did not have an excess risk for DFS loss (1.02, 0.93-1.12) or other outcomes. CONCLUSIONS: Among older people, diabetes was associated with reduced DFS, and higher risk of CIND and cardiovascular outcomes, whereas prediabetes was not. The impact of preventing or treating diabetes in this age group deserves closer attention.

来源:Age Ageing,查看原文。版权归原作者所有。

引用

  1. Zhou Z, Curtis AJ, Owen A, et al. Prediabetes, diabetes and loss of disability-free survival in a community-based older cohort: a post-hoc analysis of the ASPirin in Reducing Events in the Elderly trial. Age Ageing. 2023. PMID: 37097768. doi:10.1093/ageing/afad060

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。